Physician profile
Daniel A Brancheau
NPI 1710146725
$41,665.66
in general payments reported to CMS, 2019-2025
53 companies · $3,322 in 2025
The $3,322 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,598 · 2020: $7,055 · 2021: $8,188 · 2022: $8,523 · 2023: $5,050 · 2024: $2,929 · 2025: $3,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,051 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,051.14 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20,303.94 | 2019-2025 | Lifevest |
| Abbott Laboratories | $7,674.73 | 2019-2025 | Pressurewire, Esprit, Xience Skypoint |
| Abiomed | $4,740.13 | 2021-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $975.21 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $842.60 | 2019-2024 | Xarelto |
| Pfizer INC. | $662.12 | 2019-2025 | |
| Inari Medical, INC. | $624.78 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medical Device Business Services, INC. | $575.61 | 2019 | |
| Boston Scientific Corporation | $559.25 | 2019-2025 | Watchman Flx, General - Structural Heart, Eluvia |
| Stryker Corporation | $407.66 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Astellas Pharma US INC | $371.23 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $358.44 | 2021-2025 | Verquvo, Winrevair |
| Astrazeneca Pharmaceuticals LP | $337.72 | 2019-2025 | Farxiga |
| Actelion Pharmaceuticals US, INC. | $332.29 | 2019-2025 | Uptravi, Opsumit |
| Amgen INC. | $297.29 | 2019-2025 | Repatha, Repatha |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.42 | 2019-2025 | Jardiance, Spiriva Respimat |
| Shockwave Medical, INC | $196.08 | 2022-2025 | |
| Novo Nordisk INC | $191.07 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Cardiovascular Systems INC. | $163.57 | 2019-2023 | Diamondback Coronary |
| Biotronik INC. | $137.56 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $125.84 | 2022-2025 | Xywav |
| Abbvie INC. | $124.38 | 2023 | Teflaro, Avycaz |
| Amarin Pharma, INC. | $123.71 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $117.78 | 2021-2023 | Arcalyst |
| Edwards Lifesciences Corporation | $104.04 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $94.77 | 2021-2025 | Eliquis, Camzyos |
| Kiniksa Pharmaceuticals International, Plc | $90.43 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $87.89 | 2023-2024 | Assure Wcd |
| Cardiva Medical, INC. | $87.41 | 2022-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Cordis US Corp. | $69.19 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Teleflex LLC | $66.73 | 2019-2025 | Guideliner |
| Alnylam Pharmaceuticals INC. | $66.53 | 2021-2022 | |
| United Therapeutics Corporation | $64.51 | 2021-2025 | Tyvaso, Tyvaso |
| Esperion Therapeutics, INC. | $64.37 | 2020-2024 | Nexletol |
| Philips North America LLC | $31.90 | 2020-2022 | |
| Veryan Medical Incorporated | $31.82 | 2022 | |
| Preventice Services, LLC | $30.07 | 2019-2021 | |
| Ekos Corporation | $28.11 | 2019 | |
| Mallinckrodt Hospital Products INC. | $28.00 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $24.90 | 2019 | |
| Surmodics, INC. | $23.68 | 2024 | Pounce Venous Thrombectomy System |
| Intra-Sana Laboratories | $20.01 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Bracco Diagnostics INC. | $19.04 | 2020 | |
| Scpharmaceuticals INC. | $19.00 | 2023 | |
| Lilly USA, LLC | $16.94 | 2025 | Zepbound |
| Terumo Medical Corporation | $16.73 | 2019 | |
| Glaxosmithkline, LLC. | $16.02 | 2025 | Shingrix |
| Lundbeck LLC | $15.24 | 2019 | |
| Angiodynamics, INC. | $15.13 | 2019 | |
| Ge Healthcare | $14.88 | 2020 | |
| Amryt Pharma Holdings LTD | $14.62 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.59 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Brancheau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.